Restrictor slows RNAPII elongation to promote termination at noncoding RNA loci
Genes & Development · 01.07.2025 · 39 (13-14) · 868-885
DOI: 10.1101/gad.352654.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, online erschienen am 20.05.2025. Verfasst von Claudia A Mimoso und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA. Hauptthemen laut MEDLINE: RNA Polymerase II, RNA, Untranslated, RNA-Binding Proteins, Transcription Termination, Genetic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health, Sophia H.Y Chang Fellowship.
Abstract (Originalsprache)
The eukaryotic genome is broadly transcribed by RNA polymerase II (RNAPII) to produce protein-coding messenger RNAs (mRNAs) and a repertoire of noncoding RNAs (ncRNAs). Although RNAPII is very processive during mRNA transcription, it terminates rapidly during synthesis of many ncRNAs, particularly those that arise opportunistically from accessible chromatin at gene promoters or enhancers. The divergent fates of mRNA versus ncRNA species raise many questions about how RNAPII and associated machineries discriminate functional from spurious transcription. Restrictor, comprised of the RNA binding protein ZC3H4 and RNAPII-interacting protein WDR82, has been implicated in restraining the expression of ncRNAs. However, the determinants of Restrictor specificity and the mechanism of transcription suppression remain unclear. Here, we investigate Restrictor using unbiased sequence screens and rapid protein degradation followed by nascent RNA sequencing. We found that Restrictor promiscuously suppresses early elongation by RNAPII, but this activity is blocked at most mRNAs by the presence of a 5′ splice site. Consequently, Restrictor is a critical determinant of transcription directionality at divergent promoters and prevents transcriptional interference. Mechanistically, we show that rather than terminating RNAPII directly, Restrictor acts by reducing the rate of transcription elongation, rendering RNAPII susceptible to early termination by other machineries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
- Department of Genetics, Yale School of Medicine, New Haven, Connecticut 06510, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA; karen_adelman@hms.harvard.edu h.vlaming@uu.nl.
- Division of Genome Biology and Epigenetics, Institute of Biodynamics and Biocomplexity, Utrecht University, Utrecht 3584 CH, The Netherlands.
ORCID-Profile: Hanneke Vlaming, Karen Adelman
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- Sophia H.Y Chang Fellowship
- Human Frontier Science Program
Zitieren
APA
Mimoso, C. A., Vlaming, H., de Wagenaar, N. P., Siegenfeld, A. P., & Adelman, K. (2025). Restrictor slows RNAPII elongation to promote termination at noncoding RNA loci. Genes & Development, 39(13-14), 868-885. https://doi.org/10.1101/gad.352654.125
Vancouver
Mimoso CA, Vlaming H, de Wagenaar NP, Siegenfeld AP, Adelman K. Restrictor slows RNAPII elongation to promote termination at noncoding RNA loci. Genes & Development. 2025;39(13-14):868-885. doi:10.1101/gad.352654.125
BibTeX
@article{Mimoso2025,
author = {Mimoso, Claudia A and Vlaming, Hanneke and de Wagenaar, Nathalie P and Siegenfeld, Allison P and Adelman, Karen},
title = {Restrictor slows RNAPII elongation to promote termination at noncoding RNA loci},
journal = {Genes & Development},
year = {2025},
volume = {39},
number = {13-14},
pages = {868--885},
doi = {10.1101/gad.352654.125}
}
EUVIMED